Author:
Dehghani Behzad,Hashempour Tayebeh,Hasanshahi Zahra,Moayedi Javad
Funder
Shiraz University of Medical Sciences
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Molecular Medicine,Biochemistry,Bioengineering,Analytical Chemistry
Reference87 articles.
1. Aghasadeghi M, Sadat S, Budkowska A, Khabiri A, Amini S, Bahramali G et al (2006) Evaluation of a native preparation of HCV core protein (2-122) for potential applications in immunization, diagnosis and mAb production. Iran J Public Health 35(1):1–10
2. Ajorloo M, Bamdad T, Hashempour T, Alborzi AM, Mozhgani SHR, Asadi R et al (2015) Detection of specific antibodies to HCV-ARF/CORE + 1 protein in cirrhotic and non-cirrhotic patients with hepatitis C: a possible association with progressive fibrosis. Arch Iran Med AIM 18(5):304–307
3. Akuta N, Suzuki F, Kawamura Y, Yatsuji H, Sezaki H, Suzuki Y et al (2007) Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis. Hepatology 46(5):1357–1364
4. Akuta N, Suzuki F, Hirakawa M, Kawamura Y, Yatsuji H, Sezaki H et al (2010) Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin. Hepatology 52(2):421–429
5. Akuta N, Suzuki F, Hirakawa M, Kawamura Y, Sezaki H, Suzuki Y et al (2011) Amino acid substitutions in hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by antiviral therapy. J Med Virol 83(6):1016–1022